Seasonal Influenza Vaccines Industry Research Report 2025
Description
Summary
According to APO Research, the global Seasonal Influenza Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Seasonal Influenza Vaccines include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Seasonal Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Seasonal Influenza Vaccines.
The report will help the Seasonal Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Seasonal Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Seasonal Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Seasonal Influenza Vaccines Segment by Company
Changsheng Bio-Technology
Sanofi
Novartis International AG
Merck & Co., Inc.
Pfizer Inc
GlaxoSmithKline plc
AstraZeneca
Viatris Inc.
Vaxess Technologies Inc
Sinovac Biotech Ltd
SINOVAC
OSIVAX
Jiangsu Simcere Vaxtec Bio-pharmaceutical
EMERGEX VACCINES
EMERGENT
Dalian Hissen Bio-pharm
CSL Limited
Ccbio SA
Aleph Biomedical
Abbott Laboratories
Seasonal Influenza Vaccines Segment by Type
Type B
Type A (H3N2)
Type A (H1N1)
Seasonal Influenza Vaccines Segment by Application
Adults
Pediatrics
Elderly
Adolescence
Seasonal Influenza Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Seasonal Influenza Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Seasonal Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Seasonal Influenza Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Seasonal Influenza Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Seasonal Influenza Vaccines include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Seasonal Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Seasonal Influenza Vaccines.
The report will help the Seasonal Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Seasonal Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Seasonal Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Seasonal Influenza Vaccines Segment by Company
Changsheng Bio-Technology
Sanofi
Novartis International AG
Merck & Co., Inc.
Pfizer Inc
GlaxoSmithKline plc
AstraZeneca
Viatris Inc.
Vaxess Technologies Inc
Sinovac Biotech Ltd
SINOVAC
OSIVAX
Jiangsu Simcere Vaxtec Bio-pharmaceutical
EMERGEX VACCINES
EMERGENT
Dalian Hissen Bio-pharm
CSL Limited
Ccbio SA
Aleph Biomedical
Abbott Laboratories
Seasonal Influenza Vaccines Segment by Type
Type B
Type A (H3N2)
Type A (H1N1)
Seasonal Influenza Vaccines Segment by Application
Adults
Pediatrics
Elderly
Adolescence
Seasonal Influenza Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Seasonal Influenza Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Seasonal Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
151 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Seasonal Influenza Vaccines Market Size (2020-2031)
- 2.2.2 Global Seasonal Influenza Vaccines Sales (2020-2031)
- 2.2.3 Global Seasonal Influenza Vaccines Market Average Price (2020-2031)
- 2.3 Seasonal Influenza Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Type B
- 2.3.3 Type A (H3N2)
- 2.3.4 Type A (H1N1)
- 2.4 Seasonal Influenza Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Adults
- 2.4.3 Pediatrics
- 2.4.4 Elderly
- 2.4.5 Adolescence
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Seasonal Influenza Vaccines Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Seasonal Influenza Vaccines Sales (W Units) of Manufacturers (2020-2025)
- 3.3 Global Seasonal Influenza Vaccines Revenue of Manufacturers (2020-2025)
- 3.4 Global Seasonal Influenza Vaccines Average Price by Manufacturers (2020-2025)
- 3.5 Global Seasonal Influenza Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Seasonal Influenza Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Seasonal Influenza Vaccines, Established Date
- 3.9 Global Seasonal Influenza Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Changsheng Bio-Technology
- 4.1.1 Changsheng Bio-Technology Company Information
- 4.1.2 Changsheng Bio-Technology Business Overview
- 4.1.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
- 4.1.5 Changsheng Bio-Technology Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Novartis International AG
- 4.3.1 Novartis International AG Company Information
- 4.3.2 Novartis International AG Business Overview
- 4.3.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
- 4.3.5 Novartis International AG Recent Developments
- 4.4 Merck & Co., Inc.
- 4.4.1 Merck & Co., Inc. Company Information
- 4.4.2 Merck & Co., Inc. Business Overview
- 4.4.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
- 4.4.5 Merck & Co., Inc. Recent Developments
- 4.5 Pfizer Inc
- 4.5.1 Pfizer Inc Company Information
- 4.5.2 Pfizer Inc Business Overview
- 4.5.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
- 4.5.5 Pfizer Inc Recent Developments
- 4.6 GlaxoSmithKline plc
- 4.6.1 GlaxoSmithKline plc Company Information
- 4.6.2 GlaxoSmithKline plc Business Overview
- 4.6.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
- 4.6.5 GlaxoSmithKline plc Recent Developments
- 4.7 AstraZeneca
- 4.7.1 AstraZeneca Company Information
- 4.7.2 AstraZeneca Business Overview
- 4.7.3 AstraZeneca Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
- 4.7.5 AstraZeneca Recent Developments
- 4.8 Viatris Inc.
- 4.8.1 Viatris Inc. Company Information
- 4.8.2 Viatris Inc. Business Overview
- 4.8.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
- 4.8.5 Viatris Inc. Recent Developments
- 4.9 Vaxess Technologies Inc
- 4.9.1 Vaxess Technologies Inc Company Information
- 4.9.2 Vaxess Technologies Inc Business Overview
- 4.9.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
- 4.9.5 Vaxess Technologies Inc Recent Developments
- 4.10 Sinovac Biotech Ltd
- 4.10.1 Sinovac Biotech Ltd Company Information
- 4.10.2 Sinovac Biotech Ltd Business Overview
- 4.10.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
- 4.10.5 Sinovac Biotech Ltd Recent Developments
- 4.11 SINOVAC
- 4.11.1 SINOVAC Company Information
- 4.11.2 SINOVAC Business Overview
- 4.11.3 SINOVAC Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
- 4.11.5 SINOVAC Recent Developments
- 4.12 OSIVAX
- 4.12.1 OSIVAX Company Information
- 4.12.2 OSIVAX Business Overview
- 4.12.3 OSIVAX Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.12.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
- 4.12.5 OSIVAX Recent Developments
- 4.13 Jiangsu Simcere Vaxtec Bio-pharmaceutical
- 4.13.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
- 4.13.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
- 4.13.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.13.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
- 4.13.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
- 4.14 EMERGEX VACCINES
- 4.14.1 EMERGEX VACCINES Company Information
- 4.14.2 EMERGEX VACCINES Business Overview
- 4.14.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.14.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
- 4.14.5 EMERGEX VACCINES Recent Developments
- 4.15 EMERGENT
- 4.15.1 EMERGENT Company Information
- 4.15.2 EMERGENT Business Overview
- 4.15.3 EMERGENT Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.15.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
- 4.15.5 EMERGENT Recent Developments
- 4.16 Dalian Hissen Bio-pharm
- 4.16.1 Dalian Hissen Bio-pharm Company Information
- 4.16.2 Dalian Hissen Bio-pharm Business Overview
- 4.16.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.16.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
- 4.16.5 Dalian Hissen Bio-pharm Recent Developments
- 4.17 CSL Limited
- 4.17.1 CSL Limited Company Information
- 4.17.2 CSL Limited Business Overview
- 4.17.3 CSL Limited Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.17.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
- 4.17.5 CSL Limited Recent Developments
- 4.18 Ccbio SA
- 4.18.1 Ccbio SA Company Information
- 4.18.2 Ccbio SA Business Overview
- 4.18.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.18.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
- 4.18.5 Ccbio SA Recent Developments
- 4.19 Aleph Biomedical
- 4.19.1 Aleph Biomedical Company Information
- 4.19.2 Aleph Biomedical Business Overview
- 4.19.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.19.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
- 4.19.5 Aleph Biomedical Recent Developments
- 4.20 Abbott Laboratories
- 4.20.1 Abbott Laboratories Company Information
- 4.20.2 Abbott Laboratories Business Overview
- 4.20.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.20.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
- 4.20.5 Abbott Laboratories Recent Developments
- 5 Global Seasonal Influenza Vaccines Market Scenario by Region
- 5.1 Global Seasonal Influenza Vaccines Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Seasonal Influenza Vaccines Sales by Region: 2020-2031
- 5.2.1 Global Seasonal Influenza Vaccines Sales by Region: 2020-2025
- 5.2.2 Global Seasonal Influenza Vaccines Sales by Region: 2026-2031
- 5.3 Global Seasonal Influenza Vaccines Revenue by Region: 2020-2031
- 5.3.1 Global Seasonal Influenza Vaccines Revenue by Region: 2020-2025
- 5.3.2 Global Seasonal Influenza Vaccines Revenue by Region: 2026-2031
- 5.4 North America Seasonal Influenza Vaccines Market Facts & Figures by Country
- 5.4.1 North America Seasonal Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Seasonal Influenza Vaccines Sales by Country (2020-2031)
- 5.4.3 North America Seasonal Influenza Vaccines Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Seasonal Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Seasonal Influenza Vaccines Sales by Country (2020-2031)
- 5.5.3 Europe Seasonal Influenza Vaccines Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Seasonal Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Seasonal Influenza Vaccines Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Seasonal Influenza Vaccines Market Facts & Figures by Country
- 5.7.1 South America Seasonal Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Seasonal Influenza Vaccines Sales by Country (2020-2031)
- 5.7.3 South America Seasonal Influenza Vaccines Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Seasonal Influenza Vaccines Sales by Type (2020-2031)
- 6.1.1 Global Seasonal Influenza Vaccines Sales by Type (2020-2031) & (W Units)
- 6.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Type (2020-2031)
- 6.2 Global Seasonal Influenza Vaccines Revenue by Type (2020-2031)
- 6.2.1 Global Seasonal Influenza Vaccines Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2020-2031)
- 6.3 Global Seasonal Influenza Vaccines Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Seasonal Influenza Vaccines Sales by Application (2020-2031)
- 7.1.1 Global Seasonal Influenza Vaccines Sales by Application (2020-2031) & (W Units)
- 7.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Application (2020-2031)
- 7.2 Global Seasonal Influenza Vaccines Revenue by Application (2020-2031)
- 7.2.1 Global Seasonal Influenza Vaccines Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2020-2031)
- 7.3 Global Seasonal Influenza Vaccines Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Seasonal Influenza Vaccines Value Chain Analysis
- 8.1.1 Seasonal Influenza Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Seasonal Influenza Vaccines Production Mode & Process
- 8.2 Seasonal Influenza Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Seasonal Influenza Vaccines Distributors
- 8.2.3 Seasonal Influenza Vaccines Customers
- 9 Global Seasonal Influenza Vaccines Analyzing Market Dynamics
- 9.1 Seasonal Influenza Vaccines Industry Trends
- 9.2 Seasonal Influenza Vaccines Industry Drivers
- 9.3 Seasonal Influenza Vaccines Industry Opportunities and Challenges
- 9.4 Seasonal Influenza Vaccines Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Seasonal Influenza Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Seasonal Influenza Vaccines Sales (W Units) of Manufacturers (2020-2025)
- Table 7. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Seasonal Influenza Vaccines Revenue of Manufacturers (2020-2025)
- Table 9. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Seasonal Influenza Vaccines Average Price (US$/Unit) of Manufacturers (2020-2025)
- Table 11. Global Seasonal Influenza Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Seasonal Influenza Vaccines, Product Type & Application
- Table 14. Global Seasonal Influenza Vaccines Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Seasonal Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Changsheng Bio-Technology Company Information
- Table 19. Changsheng Bio-Technology Business Overview
- Table 20. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 21. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
- Table 22. Changsheng Bio-Technology Recent Developments
- Table 23. Sanofi Company Information
- Table 24. Sanofi Business Overview
- Table 25. Sanofi Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 26. Sanofi Seasonal Influenza Vaccines Product Portfolio
- Table 27. Sanofi Recent Developments
- Table 28. Novartis International AG Company Information
- Table 29. Novartis International AG Business Overview
- Table 30. Novartis International AG Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 31. Novartis International AG Seasonal Influenza Vaccines Product Portfolio
- Table 32. Novartis International AG Recent Developments
- Table 33. Merck & Co., Inc. Company Information
- Table 34. Merck & Co., Inc. Business Overview
- Table 35. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 36. Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
- Table 37. Merck & Co., Inc. Recent Developments
- Table 38. Pfizer Inc Company Information
- Table 39. Pfizer Inc Business Overview
- Table 40. Pfizer Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 41. Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
- Table 42. Pfizer Inc Recent Developments
- Table 43. GlaxoSmithKline plc Company Information
- Table 44. GlaxoSmithKline plc Business Overview
- Table 45. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 46. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
- Table 47. GlaxoSmithKline plc Recent Developments
- Table 48. AstraZeneca Company Information
- Table 49. AstraZeneca Business Overview
- Table 50. AstraZeneca Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 51. AstraZeneca Seasonal Influenza Vaccines Product Portfolio
- Table 52. AstraZeneca Recent Developments
- Table 53. Viatris Inc. Company Information
- Table 54. Viatris Inc. Business Overview
- Table 55. Viatris Inc. Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 56. Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
- Table 57. Viatris Inc. Recent Developments
- Table 58. Vaxess Technologies Inc Company Information
- Table 59. Vaxess Technologies Inc Business Overview
- Table 60. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 61. Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
- Table 62. Vaxess Technologies Inc Recent Developments
- Table 63. Sinovac Biotech Ltd Company Information
- Table 64. Sinovac Biotech Ltd Business Overview
- Table 65. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 66. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
- Table 67. Sinovac Biotech Ltd Recent Developments
- Table 68. SINOVAC Company Information
- Table 69. SINOVAC Business Overview
- Table 70. SINOVAC Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 71. SINOVAC Seasonal Influenza Vaccines Product Portfolio
- Table 72. SINOVAC Recent Developments
- Table 73. OSIVAX Company Information
- Table 74. OSIVAX Business Overview
- Table 75. OSIVAX Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 76. OSIVAX Seasonal Influenza Vaccines Product Portfolio
- Table 77. OSIVAX Recent Developments
- Table 78. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
- Table 79. Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
- Table 80. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 81. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
- Table 82. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
- Table 83. EMERGEX VACCINES Company Information
- Table 84. EMERGEX VACCINES Business Overview
- Table 85. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 86. EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
- Table 87. EMERGEX VACCINES Recent Developments
- Table 88. EMERGENT Company Information
- Table 89. EMERGENT Business Overview
- Table 90. EMERGENT Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 91. EMERGENT Seasonal Influenza Vaccines Product Portfolio
- Table 92. EMERGENT Recent Developments
- Table 93. Dalian Hissen Bio-pharm Company Information
- Table 94. Dalian Hissen Bio-pharm Business Overview
- Table 95. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 96. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
- Table 97. Dalian Hissen Bio-pharm Recent Developments
- Table 98. CSL Limited Company Information
- Table 99. CSL Limited Business Overview
- Table 100. CSL Limited Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 101. CSL Limited Seasonal Influenza Vaccines Product Portfolio
- Table 102. CSL Limited Recent Developments
- Table 103. Ccbio SA Company Information
- Table 104. Ccbio SA Business Overview
- Table 105. Ccbio SA Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 106. Ccbio SA Seasonal Influenza Vaccines Product Portfolio
- Table 107. Ccbio SA Recent Developments
- Table 108. Aleph Biomedical Company Information
- Table 109. Aleph Biomedical Business Overview
- Table 110. Aleph Biomedical Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 111. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
- Table 112. Aleph Biomedical Recent Developments
- Table 113. Abbott Laboratories Company Information
- Table 114. Abbott Laboratories Business Overview
- Table 115. Abbott Laboratories Seasonal Influenza Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
- Table 116. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
- Table 117. Abbott Laboratories Recent Developments
- Table 118. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 119. Global Seasonal Influenza Vaccines Sales by Region (2020-2025) & (W Units)
- Table 120. Global Seasonal Influenza Vaccines Sales Market Share by Region (2020-2025)
- Table 121. Global Seasonal Influenza Vaccines Sales by Region (2026-2031) & (W Units)
- Table 122. Global Seasonal Influenza Vaccines Sales Market Share by Region (2026-2031)
- Table 123. Global Seasonal Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
- Table 124. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2020-2025)
- Table 125. Global Seasonal Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
- Table 126. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2026-2031)
- Table 127. North America Seasonal Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 128. North America Seasonal Influenza Vaccines Sales by Country (2020-2025) & (W Units)
- Table 129. North America Seasonal Influenza Vaccines Sales by Country (2026-2031) & (W Units)
- Table 130. North America Seasonal Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 131. North America Seasonal Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 132. Europe Seasonal Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 133. Europe Seasonal Influenza Vaccines Sales by Country (2020-2025) & (W Units)
- Table 134. Europe Seasonal Influenza Vaccines Sales by Country (2026-2031) & (W Units)
- Table 135. Europe Seasonal Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 136. Europe Seasonal Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 137. Asia Pacific Seasonal Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 138. Asia Pacific Seasonal Influenza Vaccines Sales by Country (2020-2025) & (W Units)
- Table 139. Asia Pacific Seasonal Influenza Vaccines Sales by Country (2026-2031) & (W Units)
- Table 140. Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 141. Asia Pacific Seasonal Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 142. South America Seasonal Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 143. South America Seasonal Influenza Vaccines Sales by Country (2020-2025) & (W Units)
- Table 144. South America Seasonal Influenza Vaccines Sales by Country (2026-2031) & (W Units)
- Table 145. South America Seasonal Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 146. South America Seasonal Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 147. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 148. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2020-2025) & (W Units)
- Table 149. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2026-2031) & (W Units)
- Table 150. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 151. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 152. Global Seasonal Influenza Vaccines Sales by Type (2020-2025) & (W Units)
- Table 153. Global Seasonal Influenza Vaccines Sales by Type (2026-2031) & (W Units)
- Table 154. Global Seasonal Influenza Vaccines Sales Market Share by Type (2020-2025)
- Table 155. Global Seasonal Influenza Vaccines Sales Market Share by Type (2026-2031)
- Table 156. Global Seasonal Influenza Vaccines Revenue by Type (2020-2025) & (US$ Million)
- Table 157. Global Seasonal Influenza Vaccines Revenue by Type (2026-2031) & (US$ Million)
- Table 158. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2020-2025)
- Table 159. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2026-2031)
- Table 160. Global Seasonal Influenza Vaccines Price by Type (2020-2025) & (US$/Unit)
- Table 161. Global Seasonal Influenza Vaccines Price by Type (2026-2031) & (US$/Unit)
- Table 162. Global Seasonal Influenza Vaccines Sales by Application (2020-2025) & (W Units)
- Table 163. Global Seasonal Influenza Vaccines Sales by Application (2026-2031) & (W Units)
- Table 164. Global Seasonal Influenza Vaccines Sales Market Share by Application (2020-2025)
- Table 165. Global Seasonal Influenza Vaccines Sales Market Share by Application (2026-2031)
- Table 166. Global Seasonal Influenza Vaccines Revenue by Application (2020-2025) & (US$ Million)
- Table 167. Global Seasonal Influenza Vaccines Revenue by Application (2026-2031) & (US$ Million)
- Table 168. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2020-2025)
- Table 169. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2026-2031)
- Table 170. Global Seasonal Influenza Vaccines Price by Application (2020-2025) & (US$/Unit)
- Table 171. Global Seasonal Influenza Vaccines Price by Application (2026-2031) & (US$/Unit)
- Table 172. Key Raw Materials
- Table 173. Raw Materials Key Suppliers
- Table 174. Seasonal Influenza Vaccines Distributors List
- Table 175. Seasonal Influenza Vaccines Customers List
- Table 176. Seasonal Influenza Vaccines Industry Trends
- Table 177. Seasonal Influenza Vaccines Industry Drivers
- Table 178. Seasonal Influenza Vaccines Industry Restraints
- Table 179. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Seasonal Influenza Vaccines Product Image
- Figure 5. Global Seasonal Influenza Vaccines Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Seasonal Influenza Vaccines Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Seasonal Influenza Vaccines Sales (2020-2031) & (W Units)
- Figure 8. Global Seasonal Influenza Vaccines Average Price (US$/Unit) & (2020-2031)
- Figure 9. Type B Product Image
- Figure 10. Type A (H3N2) Product Image
- Figure 11. Type A (H1N1) Product Image
- Figure 12. Adults Product Image
- Figure 13. Pediatrics Product Image
- Figure 14. Elderly Product Image
- Figure 15. Adolescence Product Image
- Figure 16. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers in 2024
- Figure 17. Global Manufacturers of Seasonal Influenza Vaccines, Manufacturing Sites & Headquarters
- Figure 18. Global Top 5 and 10 Seasonal Influenza Vaccines Players Market Share by Revenue in 2024
- Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 20. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 21. Global Seasonal Influenza Vaccines Sales by Region in 2024
- Figure 22. Global Seasonal Influenza Vaccines Revenue by Region in 2024
- Figure 23. North America Seasonal Influenza Vaccines Market Size by Country in 2024
- Figure 24. North America Seasonal Influenza Vaccines Sales Market Share by Country (2020-2031)
- Figure 25. North America Seasonal Influenza Vaccines Revenue Market Share by Country (2020-2031)
- Figure 26. United States Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 27. Canada Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 28. Europe Seasonal Influenza Vaccines Market Size by Country in 2024
- Figure 29. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2020-2031)
- Figure 30. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2020-2031)
- Figure 31. Germany Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. France Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. U.K. Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. Italy Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Netherlands Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Nordic Countries Seasonal Influenza Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Asia P
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
